Cromos Pharma, where the patients are

Archives

Choose a date range

From To

Choose one or more categories

Categories:



 


New structure for NIHR Clinical Research Network

Thursday, April 3, 2014 11:06 AM

The National Institute for Health Research (NIHR) Clinical Research Network, which provides more than $471.4 million a year to support the delivery of clinical research studies in the NHS, has reconfigured and will be operating in a new streamlined structure.

More... »

CRF Health eCOA webinar series

CTI Clinical Trial and Consulting Services to open new office

Thursday, April 3, 2014 10:58 AM

CTI Clinical Trial and Consulting Services, a global, privately held, full-service CRO, will relocate the company’s Consulting and Health Economics and Outcomes Research (HECOR) divisions to University Station adjacent to the Xavier University campus in Cincinnati, Ohio.

More... »


EnVivo Pharmaceuticals becomes FORUM Pharmaceuticals

Thursday, April 3, 2014 10:57 AM

EnVivo Pharmaceuticals has changed its name to FORUM Pharmaceuticals. The new name better reflects the company’s strong position as a late-stage, purpose-built organization that is focused on conquering brain diseases such as schizophrenia and Alzheimer’s disease. It is not associated with any changes in organizational structure or the company’s investor base.

More... »

Evotec, Debiopharm Group to collaborate on new treatment for cancer

Thursday, April 3, 2014 10:55 AM

Evotec has formed a research collaboration and licensing deal with Debiopharm Group, a Swiss-based global biopharmaceutical group, to identify and develop novel compounds having the potential to treat multiple forms of solid tumors and leukemia’s with defined genetic alterations. Discovery and preclinical development efforts will be driven by Evotec, while Debiopharm will manage clinical development. Evotec will receive R&D funding and high double-digit total payments triggered by clinical, regulatory and commercial milestones, plus royalties on sales of resulting commercial products.

More... »

FDA grants IND approval for CardioCell’s phase IIa itMSC Therapy trial

Wednesday, April 2, 2014 03:41 PM

CardioCell, a global biotechnology company, has just received the FDA’s Investigational New Drug (IND) approval for a U.S.-based, phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with chronic heart failure (CHF), which generates more than one million hospitalizations annually. Preparation is underway to initiate the study at Emory University, Northwestern University and the University of Pennsylvania in May 2014.

More... »

Society for Women’s Health Research urges FDA to require trials to examine gender-based differences

Wednesday, April 2, 2014 02:09 PM

Seeking to increase the participation of women and minorities in all phases of clinical trials, along with greater reporting and analysis of gender differences, Phyllis Greenberger testified at an FDA hearing yesterday. She presented a series of recommendations and changes to how the agency handles the collection, analysis and availability of demographic subgroup data in applications for FDA-regulated medical products.  

More... »

TI Pharma in $13M consortium addressing neglected parasitic diseases

Wednesday, April 2, 2014 02:00 PM

Five academic institutions, two governmental institutes and two leading SMEs from Europe, Africa and Latin America are joining forces to develop novel drugs against parasites. The four-year E.U.-funded project led by VU University Amsterdam is called PDE4NPD: PhosphoDiEsterase inhibitors for Neglected Parasitic Diseases.

More... »

CROnos Clinical Consulting to launch E-learning platform

Wednesday, April 2, 2014 01:59 PM

CROnos Clinical Consulting, a global provider of centralized risk-based data monitoring and data visualization solutions for neuroscience clinical trials, is launching an e-learning and mobile platform that will enable sponsors to transmit clinical knowledge to sites and study teams.

More... »

GlaxoSmithKline invests in Africa

Wednesday, April 2, 2014 01:54 PM

GlaxoSmithKline has announced a series of new investments in sub-Saharan Africa designed to address pressing health needs and contribute to long-term business growth. GSK CEO Sir Andrew Wittyhasset out the company’s intent to partner with governments of African countries to help stimulate more research into chronic diseases, increase capacity by localizing medicines supply and strengthen healthcare infrastructure.

More... »

Congress approves one-year renewal diabetes research funding

Wednesday, April 2, 2014 01:51 PM

The U.S. Senate has approved legislation for a one-year extension of the Special Diabetes Program (SDP)—an initiative that accounts for roughly one-third of all federally funded type 1 diabetes (T1D) research in the U.S. The decision comes on the heels of the March 27 approval of the legislation by the U.S. House of Representatives, and will extend SDP funding for the National Institutes of Health (NIH) at the current level of $150 million, as part of the “Protecting Access to Medicare Act of 2014.”

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 21

Healthcare IPOs soar in first quarter

Survey compares 'push/pull' tactics in patient recruitment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs